{"id":"W2024080866","doi":"10.1007/s10637-007-9045-8","title":"Erlotinib and vinorelbine in advanced malignant solid tumors: a phase I study","year":2007,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"University of California, Davis","keywords":"Vinorelbine; Erlotinib; Medicine; Internal medicine; Vinca alkaloid; Neutropenia; Febrile neutropenia; Oncology; Lung cancer; Mucositis; Epidermal growth factor receptor; Combination therapy; Pharmacology; Chemotherapy; Gastroenterology; Cancer; Vincristine; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002331452,0.001649234,0.004475247,0.0006418478,0.0005034483,0.001277151,0.001264376,0.001678047,0.003185359],"category_scores_gemma":[0.001156089,0.0009286737,0.002201886,0.0007972304,0.001219876,0.001457289,0.0003810228,0.003899508,0.0006135777],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001399629,"about_ca_system_score_gemma":0.001664514,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001826179,"about_ca_topic_score_gemma":0.004490627,"domain_scores_codex":[0.9992167,0.0003611873,0.0000344495,0.0001140041,0.00007023504,0.0002033586],"domain_scores_gemma":[0.9991012,0.0002518436,0.0001612857,0.0001057292,0.00004298428,0.0003369732],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7794762,0.06459075,0.00499723,0.0009859088,0.00320146,0.00029077,0.0002555394,0.004548773,0.02399041,0.0004106201,0.00355138,0.113701],"study_design_scores_gemma":[0.618855,0.3586503,0.01074419,0.0000464804,0.001488606,0.0004324634,0.00008894291,0.001340825,0.004288805,0.0001908943,0.003822016,0.00005147601],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901938,0.005355063,0.0003285878,0.0004600112,0.0001294603,0.0009016267,0.001131789,0.00006409115,0.001435502],"genre_scores_gemma":[0.9859272,0.006312978,0.001119662,0.0005687937,0.0002284024,0.001119264,0.00216698,0.00004639688,0.002510313],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004475247,"threshold_uncertainty_score":0.01233006,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01803718802920216,"score_gpt":0.3682471109087651,"score_spread":0.3502099228795629,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}